Skip to content
Screener

Personalis, Inc. PSNL Short-Term Investments

Short-Term Investments at other companies

Illumina logo
IlluminaILMN
$128M-42.1%
Guardant Health logo
Guardant HealthGH
$113.47M
GeneDx Holdings logo
GeneDx HoldingsWGS
$76.76M+29.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$252.9M
Castle Biosciences logo
Castle BiosciencesCSTL
$5.6M-96.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$1.01B-14.1%

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.51B+279%
Enterprise value$1.48B+283%
P/S23.4×+18.5×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The source filing: Personalis, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211896
Line itemMarch 31, 2026December 31, 2025
Assets
Current assets
Cash and cash equivalents$73,594$124,245
Short-term investments159,624115,708
Accounts receivable, net (1)13,02216,203
Inventory and other deferred costs6,9306,144
Prepaid expenses and other current assets5,0285,651
Total current assets258,198267,951

Item 1. Financial Statements

FAQ

What is Personalis, Inc.'s short-term investments?
Personalis, Inc. (PSNL) reported short-term investments of $159.62M in Q1 2026.
How has Personalis, Inc.'s short-term investments changed year-over-year?
Personalis, Inc.'s short-term investments increased by 39.2% year-over-year, from $114.69M to $159.62M.
What is the long-term trend for Personalis, Inc.'s short-term investments?
Over 5 years (2020 to 2025), Personalis, Inc.'s short-term investments has grown at a -3.0% compound annual growth rate (CAGR), from $134.77M to $115.71M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Ask your AI about Personalis, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude